SEC FILLINGS DISCLOSED/ Sep 12, $Janux Therapeutics (JANX.US)$ 10% Stockholder Avalon BioVentures SPV I, L.P. intends to sell 161.36K shares of its common stock on Sep 12, with a total market value of approximately $7.58 million.
Avalon BioVentures SPV I, L.P. has reduced shareholding in $Janux Therapeutics (JANX.US)$ by 157.25K shares since Sep 6, 2024, with a total value of approximately $6.77 million.
What is Form 144?
Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.
